Development of a low seroprevalence, avß6 integrin 1 selective virotherapy based on human adenovirus type 10. (2022)

First Author: Bates, E. A.
Attributed to:  MICA: Targeting the Wnt Receptor Frizzled-7 for the Treatment of Gastric Cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Publication URI: http://doi.org/10.1016/j.omto.2022.03.007

Type: Journal Article/Review

Parent Publication: Molecular Therapy: Oncolytics.